Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

EndoTraps

EndoTraps?uq=UG6efJS6
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
$100K LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of endothelin-1 traps. The company develops endothelin-1 traps which are antibody-based fusion proteins that could bind and sequester the increased levels of endothelin-1 found in different diseases.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Pharmaceuticals
Primary Office
  • England
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore EndoTraps’s full profile, request a free trial.

EndoTraps Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator $100K 00000 Completed Startup
1. Accelerator/Incubator 12-Apr-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

EndoTraps Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Accelerate Cambridge Accelerator/Incubator Minority 000 0000 000000 0
Founder.org Accelerator/Incubator Minority 000 0000 000000 0

EndoTraps Executive Team (1)

Name Title Board
Seat
Contact
Info
Helene Fox Co-Founder